Clinical Trial Details

Short Title
Official Title

Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycemic control in children and adolescents with type 2 diabetes.  A 26-week double-blind, randomized, parallel group, placebo controlled multi-center trial followed by a 26-week open-label extension


UIHC Department of Pediatrics/Division of Endocrinology are inviting children between the age of 10-17 years who have been diagnosed with type 2 diabetes to participate in a research study testing an investigational medicine called liraglutide.  Call 1-866-309-0837 if interested. Compensation av

Start Date
October 15, 2013
End Date
October 15, 2015
Gender Preference
Age Group
10 - 17 years
Principal Investigator
Eva Tsalikian, MD
Contact Info

Sarah Salamati 1-866-309-0837

diabetes ; liraglutide ;

We'd welcome your feedback!

Please help us improve your experience on our website by completing a brief survey

Yes, I'll give feedback No, Thanks